Lack of association of common polymorphism of LRP1 gene with myocardial infarction in a Chinese Han population

Abstract

This study examined the association of a common polymorphic allele (25G) of the low-density lipoprotein receptor-related protein1 (LRP1) gene with myocardial infarction (MI). The genotypes of LRP1 25CG (rs35282763) were determined in 347 MI patients and 347 age- and sex-frequency-matched controls from an unrelated Chinese Han population. Factor VIII (FVIII) levels were measured in the MI patients and controls by chromogenic assay and enzyme-linked immunosorbent assay (ELISA). The results showed that LRP1 25CG (rs35282763) genotype distribution did not differ significantly between patients (n=206 for 25CC, n=122 for 25CG) and controls (n=191 for 25CC, n=126 for 25CG; P>0.05). The 25G allele was not associated with a reduced risk of MI (P>0.05). Further stratifications for age, sex, and other cardiovascular risk factors did not affect the negative findings. It was concluded that the presence of the G allele at the 25CG (rs35282763) polymorphism of the LRP1 is not associated with a reduced risk of MI, and genotyping for LRP1 25CG (rs35282763) polymorphism is not useful in assessing the individual risk of MI.

Keywords

low-density lipoprotein receptor-related protein1 / myocardial infarction / polymorphism

References

[1] KamphuisenP.W., EikenboomJ.C., BertinaR.M.. Elevated F VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol, 2001, 21(5): 731-738

[2] TracyR.P., ArnoldA.M., EttingerW., et al.. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. Arterioscler Thromb Vasc Biol, 1999, 19(7): 1776-1783

[3] RumleyA., LoweG.D., SweetnamP.M., et al.. FVIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study. Br J Haematol, 1999, 105(1): 110-116

[4] MeadeT.W., CooperJ.A., StirlingY., et al.. FVIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol, 1994, 88(3): 601-607

[5] FolsomA.R., WuK.K., RosamondW.D., et al.. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation, 1997, 96(4): 1102-1108

[6] FolsomA.R., RosamondW.D., ShaharE., et al.. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation, 1999, 100(7): 736-742

[7] CunninghamN., LaffanM.A., ManningR.A., et al.. Low-density lipoprotein receptor-related protein polymorphisms in patients with elevated FVIII coagulant activity and venous thrombosis. Blood Coagul Fibrinolysis, 2005, 16(7): 465-468

[8] GonzalezP., AlvarezR., RegueroJ.R., et al.. Variation in the lipoprotein receptor-related protein, alpha2-macroglobulin and lipoprotein receptor-associated protein genes in relation to plasma lipid levels and risk of early myocardial infarction. Coron Artery Dis, 2002, 13(5): 251-254

[9] VormittagR., BencurP., AyC., et al.. Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting FVIII activity and increases the risk of venous thromboembolism. J Thromb Haemost, 2007, 5(3): 497-502

[10] MarchettiG., LunghiB., LegnaniC., et al.. Contribution of low density lipoprotein receptor-related protein genotypes to coagulation FVIII levels in thrombotic women. Haematologica, 2006, 91(9): 1261-1263

[11] RobertsonJ.O., LiW., SilversteinR.L., et al.. Deficiency of LR18 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis. Thromb Res, 2009, 123(4): 644-652

[12] MoebusS., BalijepalliC., LoschC., et al.. Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome—A cross-sectional study. Cardiovasc Diabetol, 2010, 9: 34

[13] Andersen KK, Andersen ZJ, Olsen TS. Age- and gender-specific prevalence of cardiovascular risk factors in 40,102 patients with first-ever ischemic stroke: a Nationwide Danish Study. Stroke,41(12):2768–2774

[14] MaloneD.C., BoudreauD.M., NicholsG.A., et al.. Association of cardiometabolic risk factors and prevalent cardiovascular events. Metab Syndr Relat Disord, 2009, 7(6): 585-593

[15] BankI., LibourelE.J., MiddeldorpS., et al.. Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. J Thromb Haemost, 2005, 3(1): 79-84

[16] KamphuisenP.W., KamphuisenE.J., BertinaR.M.. Elevated FVIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol, 2001, 21(5): 731-738

[17] TripodiA.. Levels of coagulation factors and venous thromboembolism. Haematologica, 2003, 88(6): 705-711

[18] KyrleP.A., MinarE., HirschlM., et al.. High plasma levels of FVIII and the risk of recurrent venous thromboembolism. N Engl J Med, 2000, 343(7): 457-462

[19] SarafanovA.G., MakogonenkoE.M., AndersenO.M., et al.. Localization of the low-density lipoprotein receptor-related protein regions involved in binding to the A2 domain of coagulation FVIII. Thromb Haemost, 2007, 98(6): 1170-1181

[20] SaenkoE.L., YakhyaevA.V., MikhailenkoI., et al.. Role of the low density lipoprotein-related protein receptor in mediation of FVIII catabolism. J Biol Chem, 1999, 274(53): 37685-37692

[21] AnanyevaN.M., MakogonenkoY.M., KouiavskaiaD.V., et al.. The binding sites for the very low density lipoprotein receptor and low-density lipoprotein receptor-related protein are shared within coagulation FVIII. Blood Coagul Fibrinolysis, 2008, 19(2): 166-177

[22] O’DonnellJ., TuddenhamE.G., ManningR., et al.. High prevalence of elevated FVIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost, 1997, 77(5): 825-828

[23] KraaijenhagenR.A., AnkerP.S., KoopmanM.M., et al.. High plasma concentration of FVIIIc is a major risk factor for venous thromboembolism. Thromb Haemost, 2000, 83(21): 5-9

[24] LentingP.J., NeelsJ.G., van den BergB.M., et al.. The light chain of FVIII comprises a binding site for low density lipoprotein receptor-related protein. J Biol Chem, 1999, 274(34): 23734-237399